Uni-Bio Science Group Ltd Intrinsic Valuation and Fundamental Analysis - Uni-Bio Science Group Ltd - Alpha Spread

Uni-Bio Science Group Ltd
HKEX:690

Watchlist Manager
Uni-Bio Science Group Ltd Logo
Uni-Bio Science Group Ltd
HKEX:690
Watchlist
Price: 0.077 HKD Market Closed
Market Cap: 483.5m HKD
Have any thoughts about
Uni-Bio Science Group Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Uni-Bio Science Group Ltd stock under the Base Case scenario is 0.099 HKD. Compared to the current market price of 0.077 HKD, Uni-Bio Science Group Ltd is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
0.099 HKD
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Uni-Bio Science Group Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Uni-Bio Science Group Ltd based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?
How do you feel about Uni-Bio Science Group Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Uni-Bio Science Group Ltd

Provide an overview of the primary business activities
of Uni-Bio Science Group Ltd.

What unique competitive advantages
does Uni-Bio Science Group Ltd hold over its rivals?

What risks and challenges
does Uni-Bio Science Group Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Uni-Bio Science Group Ltd.

Provide P/S
for Uni-Bio Science Group Ltd.

Provide P/E
for Uni-Bio Science Group Ltd.

Provide P/OCF
for Uni-Bio Science Group Ltd.

Provide P/FCFE
for Uni-Bio Science Group Ltd.

Provide P/B
for Uni-Bio Science Group Ltd.

Provide EV/S
for Uni-Bio Science Group Ltd.

Provide EV/GP
for Uni-Bio Science Group Ltd.

Provide EV/EBITDA
for Uni-Bio Science Group Ltd.

Provide EV/EBIT
for Uni-Bio Science Group Ltd.

Provide EV/OCF
for Uni-Bio Science Group Ltd.

Provide EV/FCFF
for Uni-Bio Science Group Ltd.

Provide EV/IC
for Uni-Bio Science Group Ltd.

Compare the intrinsic valuations
of Uni-Bio Science Group Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Uni-Bio Science Group Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Uni-Bio Science Group Ltd compared to its peers.

Compare the P/E ratios
of Uni-Bio Science Group Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Uni-Bio Science Group Ltd with its peers.

Analyze the financial leverage
of Uni-Bio Science Group Ltd compared to its main competitors.

Show all profitability ratios
for Uni-Bio Science Group Ltd.

Provide ROE
for Uni-Bio Science Group Ltd.

Provide ROA
for Uni-Bio Science Group Ltd.

Provide ROIC
for Uni-Bio Science Group Ltd.

Provide ROCE
for Uni-Bio Science Group Ltd.

Provide Gross Margin
for Uni-Bio Science Group Ltd.

Provide Operating Margin
for Uni-Bio Science Group Ltd.

Provide Net Margin
for Uni-Bio Science Group Ltd.

Provide FCF Margin
for Uni-Bio Science Group Ltd.

Show all solvency ratios
for Uni-Bio Science Group Ltd.

Provide D/E Ratio
for Uni-Bio Science Group Ltd.

Provide D/A Ratio
for Uni-Bio Science Group Ltd.

Provide Interest Coverage Ratio
for Uni-Bio Science Group Ltd.

Provide Altman Z-Score Ratio
for Uni-Bio Science Group Ltd.

Provide Quick Ratio
for Uni-Bio Science Group Ltd.

Provide Current Ratio
for Uni-Bio Science Group Ltd.

Provide Cash Ratio
for Uni-Bio Science Group Ltd.

What is the historical Revenue growth
over the last 5 years for Uni-Bio Science Group Ltd?

What is the historical Net Income growth
over the last 5 years for Uni-Bio Science Group Ltd?

What is the current Free Cash Flow
of Uni-Bio Science Group Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Uni-Bio Science Group Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Uni-Bio Science Group Ltd

Current Assets 296.4m
Cash & Short-Term Investments 164.9m
Receivables 91.3m
Other Current Assets 40.2m
Non-Current Assets 190.7m
PP&E 130.4m
Intangibles 39.2m
Other Non-Current Assets 21.2m
Current Liabilities 118.3m
Accounts Payable 57.1m
Other Current Liabilities 61.2m
Non-Current Liabilities 56.1m
Long-Term Debt 56.1m
Efficiency

Earnings Waterfall
Uni-Bio Science Group Ltd

Revenue
508.4m HKD
Cost of Revenue
-83.8m HKD
Gross Profit
424.6m HKD
Operating Expenses
-319.9m HKD
Operating Income
104.7m HKD
Other Expenses
-5.8m HKD
Net Income
98.9m HKD

Free Cash Flow Analysis
Uni-Bio Science Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Uni-Bio Science Group Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

64/100
Profitability
Score

Uni-Bio Science Group Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Uni-Bio Science Group Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Negative Net Debt
Long-Term Solvency
73/100
Solvency
Score

Uni-Bio Science Group Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Uni-Bio Science Group Ltd

There are no price targets for Uni-Bio Science Group Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Uni-Bio Science Group Ltd?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for Uni-Bio Science Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about Uni-Bio Science Group Ltd dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

Price
Uni-Bio Science Group Ltd

1M 1M
+45%
6M 6M
-6%
1Y 1Y
+45%
3Y 3Y
-21%
5Y 5Y
-60%
10Y 10Y
-65%
Annual Price Range
0.077
52w Low
0.041
52w High
0.097
Price Metrics
Average Annual Return -21.93%
Standard Deviation of Annual Returns 7.33%
Max Drawdown -82%
Shares Statistics
Market Capitalization 468m HKD
Shares Outstanding 6 278 768 147
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

Uni-Bio Science Group Ltd Logo
Uni-Bio Science Group Ltd

Country

Hong Kong

Industry

Biotechnology

Market Cap

468m HKD

Dividend Yield

0%

Description

Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The company employs 326 full-time employees The company went IPO on 2001-11-12. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.

Contact

Unit 502, 5/F, No.20 Science Park East Avenue, Hong Kong Science Park, Shatin, New Territories
+85231023232.0
www.uni-bioscience.com

IPO

2001-11-12

Employees

326

Officers

See Also

Discover More
What is the Intrinsic Value of one Uni-Bio Science Group Ltd stock?

The intrinsic value of one Uni-Bio Science Group Ltd stock under the Base Case scenario is 0.099 HKD.

Is Uni-Bio Science Group Ltd stock undervalued or overvalued?

Compared to the current market price of 0.077 HKD, Uni-Bio Science Group Ltd is Undervalued by 22%.

Back to Top